ネブライザーのアメリカ市場規模・シェア・動向分析

◆英語タイトル:U.S. Nebulizer Market Size, Share & Trends Analysis Report By Product (Pneumatic (Standalone, Portable), Ultrasonic, Mesh), Competitive Landscape, And Segment Forecasts, 2018 - 2025
◆発行会社/調査会社:Grand View Research
◆商品コード:GVIEW803034
◆発行日:2018年2月15日
◆調査対象地域:米国
◆産業分野:医療機器
◆ページ数:78
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥874,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,094,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ネブライザーのアメリカ市場規模・シェア・動向分析]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

The U.S. nebulizer market size is anticipated to reach USD 435.5 million by 2025, according to a new report by Grand View Research, Inc., expanding at a 6.2% CAGR during the forecast period. Rising incidence of chronic respiratory diseases in U.S., increasing demand for home healthcare devices, and growing geriatric population are among the key factors driving market growth.
Rising incidence of chronic respiratory diseases is a crucial driver for market growth. According to statistics published by the Centers for Disease Control and Prevention (CDC), approximately 18.4 million adults in U.S. suffer from asthma. Chronic obstructive pulmonary disease (COPD) was estimated to be the third leading cause of death in the country in 2014, according to the CDC, with around 15.7 million Americans diagnosed with the condition that year. Factors such as overconsumption of tobacco and alcohol, unhealthy diet, lack of physical activity, and alarming rates of obesity are also likely to lead to an increase in incidence of respiratory disorders in U.S., contributing to the growth of the nebulizer market over the forecast period.

Home healthcare devices have been gaining popularity and market share in recent years. Growing geriatric population in U.S., high incidence of target diseases, and rising need to curb healthcare expenditure are expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays. Easy availability of compact nebulizers ideal for home use and technological innovations in nebulizers to reduce noise and improve functionality are increasing their adoption in home healthcare. Moreover, third-party payers, such as insurance companies, favor such devices as they aim to reduce costs while providing quality healthcare services. Such factors are also expected to contribute to market growth.

Further key findings from the study suggest:

• Pneumatic nebulizer accounted for the largest share, by product, in 2016. Factors such as high prevalence of respiratory disorders in aging population have contributed to the dominant share commanded by these devices

• Mesh nebulizer is anticipated to be the fastest growing segment over the forecast period. Technological advancements in these devices will propel growth

• Major players in the market include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; Allied Healthcare Products, Inc.; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; Briggs Healthcare; Drive Medical; and GF Health Products, Inc.

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Region Wise Market Calculation
1.3.1 Region Wise Market: Base Estimates
1.3.2 U.S Market: CAGR Calculation
1.4 List of Secondary Sources (partial list)
Chapter 2 Executive Summary
2.1 U.S. Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 U.S. Market Segmentation and Scope
3.2 U.S. Market Driver Analysis
3.2.1 Rising incidence of chronic respiratory diseases
3.2.2 Increasing demand for home healthcare devices
3.2.3 Rising geriatric population base
3.3 Market Restraint Analysis
3.3.1 Drug loss during drug delivery
3.4 Penetration & Growth Prospects Mapping
3.5 U.S. Nebulizer Market – PESTLE Analysis
3.6 Industry Analysis – Porter’s
Chapter 4 U.S. Nebulizer Market: Product Estimates & Trend Analysis
4.1 U.S. Nebulizer Market: Product Movement Analysis
4.2 Pneumatic nebulizer
4.2.1 U.S. Pneumatic nebulizer market, 2014 – 2025 (USD Million)
4.2.2 U.S. Pneumatic nebulizer market, 2014 – 2025 (Units)
4.2.3 Standalone (non-portable)/tabletop pneumatic nebulizer
4.2.3.1 U.S. Standalone pneumatic nebulizer market, 2014 – 2025 (USD Million)
4.2.3.2 U.S. Standalone pneumatic nebulizer market, 2014 – 2025 (Units)
4.2.4 Portable pneumatic nebulizer
4.2.4.1 U.S. Portable pneumatic nebulizer market, 2014 – 2025 (USD Million)
4.2.4.2 U.S. Portable pneumatic nebulizer market, 2014 – 2025 (Units)
4.3 Ultrasonic nebulizer
4.3.1 U.S. Ultrasonic nebulizer market, 2014 – 2025 (USD Million)
4.3.2 U.S. Ultrasonic nebulizer market, 2014 – 2025 (Units)
4.3.3 Standalone large-volume ultrasonic nebulizer
4.3.3.1 U.S. Standalone ultrasonic nebulizer market, 2014 – 2025 (USD Million)
4.3.3.2 U.S. Standalone ultrasonic nebulizer market, 2014 – 2025 (Units)
4.3.4 Portable ultrasonic nebulizer
4.3.4.1 U.S. Portable ultrasonic nebulizer market, 2014 – 2025 (USD Million)
4.3.4.2 U.S. Portable ultrasonic nebulizer market, 2014 – 2025 (Units)
4.4 Mesh nebulizer
4.4.1 U.S. Mesh nebulizer market, 2014 – 2025 (USD Million)
4.4.2 U.S. Mesh nebulizer market, 2014 – 2025 (Units)
Chapter 5 U.S. Nebulizer Market: Regional Estimates & Trend Analysis, by Product
5.1 Nebulizer Market Share by Region, 2016 & 2025
5.2 North America
5.2.1 North America nebulizer market, 2014 – 2025 (USD Million)
5.2.2 North America nebulizer market, 2014 – 2025 (Units)
5.2.3 U.S.
5.2.3.1 U.S. nebulizer market, 2014 – 2025 (USD Million)
5.2.3.2 U.S. nebulizer market, 2014 – 2025 (Units)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Company Profiles
6.2.1 Omron Corporation
6.2.1.1 Company overview
6.2.1.2 Financial performance
6.2.1.3 Product benchmarking
6.2.1.4 Strategic initiatives
6.2.2 Koninklijke Philips N.V.
6.2.2.1 Company overview
6.2.2.2 Financial performance
6.2.2.3 Product benchmarking
6.2.2.4 Strategic initiatives
6.2.3 PARI Pharma
6.2.3.1 Company overview
6.2.3.2 Product benchmarking
6.2.3.3 Strategic initiatives
6.2.4 Allied Healthcare Products, Inc.
6.2.4.1 Company overview
6.2.4.2 Financial performance
6.2.4.3 Product benchmarking
6.2.5 Becton, Dickinson and Company
6.2.5.1 Company overview
6.2.5.2 Financial performance
6.2.5.3 Product benchmarking
6.2.5.4 Strategic initiatives
6.2.6 Agilent Technologies
6.2.6.1 Company overview
6.2.6.2 Financial performance
6.2.6.3 Product benchmarking
6.2.7 Medline Industries, Inc.
6.2.7.1 Company overview
6.2.7.2 Product benchmarking
6.2.7.3 Strategic initiatives
6.2.8 Briggs Healthcare
6.2.8.1 Company overview
6.2.8.2 Product benchmarking
6.2.9 Drive Medical
6.2.9.1 Company overview
6.2.9.2 Product benchmarking
6.2.9.3 Strategic initiatives
6.2.10 GF Health Products, Inc.
6.2.10.1 Company overview
6.2.10.2 Product benchmarking
6.2.10.3 Strategic initiatives


List of Tables

TABLE 1 Global Nebulizer Market, by Region, 2014 - 2025 (USD Million)
TABLE 2 Global Nebulizer Market, by Product, 2014 - 2025 (USD Million)
TABLE 3 Global Pneumatic Nebulizer Market, by Type, 2014 - 2025 (USD Million)
TABLE 4 Global Ultrasonic Nebulizer Market, by Type, 2014 - 2025 (USD Million)
TABLE 5 U.S. Nebulizer Market, by Product, 2014 - 2025 (USD Million)
TABLE 6 U.S. Pneumatic Nebulizer Market, by Type, 2014 - 2025 (USD Million)
TABLE 7 U.S. Ultrasonic Nebulizer Market, by Type, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain Based Sizing & Forecasting
FIG. 6 QFD Modelling For Market Share Assessment
FIG. 7 U.S. Market Summary, (USD Million), 2016
FIG. 8 U.S. Market Trends & Outlook
FIG. 9 U.S. Market Segmentation & Scope
FIG. 10 U.S. Market driver relevance analysis (Current & Future Impact)
FIG. 11 Treatment cost by healthcare setting (Average cost per day in USD)
FIG. 12 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 13 Penetration & Growth Prospect Mapping
FIG. 14 U.S. Nebulizer Market - PESTLE Analysis
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 U.S. Nebulizer Market Product Outlook Key Takeaways
FIG. 17 U.S. Nebulizer market: Product movement analysis
FIG. 18 U.S. Pneumatic nebulizer market, 2014 - 2025 (USD Million)
FIG. 19 U.S. Pneumatic nebulizer market, 2014 - 2025 (Units)
FIG. 20 U.S. Standalone pneumatic nebulizer market, 2014 - 2025 (USD Million)
FIG. 21 U.S. Standalone pneumatic nebulizer market, 2014 - 2025 (Units)
FIG. 22 U.S. Portable pneumatic nebulizer market, 2014 - 2025 (USD Million)
FIG. 23 U.S. Portable pneumatic nebulizer market, 2014 - 2025 (Units)
FIG. 24 U.S. Ultrasonic nebulizer market, 2014 - 2025 (USD Million)
FIG. 25 U.S. Ultrasonic nebulizer market, 2014 - 2025 (Units)
FIG. 26 U.S. Standalone ultrasonic nebulizer market, 2014 - 2025 (USD Million)
FIG. 27 U.S. Standalone ultrasonic nebulizer market, 2014 - 2025 (Units)
FIG. 28 U.S. Portable ultrasonic nebulizer market, 2014 - 2025 (USD Million)
FIG. 29 U.S. Portable ultrasonic nebulizer market, 2014 - 2025 (Units)
FIG. 30 U.S. Mesh nebulizer market, 2014 - 2025 (USD Million)
FIG. 31 U.S. Mesh nebulizer market, 2014 - 2025 (Units)
FIG. 32 Regional Market Place: Key Takeaways
FIG. 33 Regional outlook, 2016 & 2025
FIG. 34 North America nebulizer market, 2014 - 2025 (USD Million)
FIG. 35 U.S. nebulizer market, 2014 - 2025 (USD Million)
FIG. 36 Strategy framework

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GVIEW803034 )"ネブライザーのアメリカ市場規模・シェア・動向分析" (英文:U.S. Nebulizer Market Size, Share & Trends Analysis Report By Product (Pneumatic (Standalone, Portable), Ultrasonic, Mesh), Competitive Landscape, And Segment Forecasts, 2018 - 2025)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。